UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers

British journal of cancer, 2016-06, Vol.115 (1), p.25-33

2016

Volltextzugriff (PDF)

Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors

PloS one, 2016-08, Vol.11 (8), p.e0161475-e0161475

2016

Volltextzugriff (PDF)

Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study - (NCT05103020) - study protocol

BMC cancer, 2023-07, Vol.23 (1), p.691-691, Article 691

2023

Volltextzugriff (PDF)

Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer

European radiology, 2012-08, Vol.22 (8), p.1693-1700

2012

Volltextzugriff (PDF)

Machine Learning-Based Mortality Prediction Model for Critically Ill Cancer Patients Admitted to the Intensive Care Unit (CanICU)

Cancers, 2023-01, Vol.15 (3), p.569

2023

Volltextzugriff (PDF)

Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer

Cancer medicine (Malden, MA), 2023-11, Vol.12 (22), p.21057-21067

2023

Volltextzugriff (PDF)

Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer

Radiation oncology (London, England), 2022-05, Vol.17 (1), p.100-100, Article 100

2022

Volltextzugriff (PDF)

Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors

Cancers, 2022-05, Vol.14 (11), p.2659

2022

Volltextzugriff (PDF)

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma

Therapeutic advances in medical oncology, 2022, Vol.14, p.175883592211132-17588359221113266

2022

Volltextzugriff (PDF)

Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial

Trials, 2020-04, Vol.21 (1), p.320-7, Article 320

2020

Volltextzugriff (PDF)

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery

BMC cancer, 2017-09, Vol.17 (1), p.615-615, Article 615

2017

Volltextzugriff (PDF)

Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent

Investigational new drugs, 2013-02, Vol.31 (1), p.1-13

2013

Volltextzugriff (PDF)

A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer

Investigational new drugs, 2014-06, Vol.32 (3), p.561-568

2014

Volltextzugriff (PDF)

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

The New England journal of medicine, 2024-03, Vol.390 (10), p.875

2024

Volltextzugriff (PDF)

Autonomy is not but competence and relatedness are associated with physical activity among colorectal cancer survivors

Supportive care in cancer, 2021-03, Vol.29 (3), p.1653-1661

2021

Volltextzugriff (PDF)

Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection

Annals of surgical oncology, 2020-08, Vol.27 (8), p.2774-2783

2020

Volltextzugriff (PDF)

A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer

Investigational new drugs, 2021-10, Vol.39 (5), p.1335-1347

2021

Volltextzugriff (PDF)

A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors

Investigational new drugs, 2017-12, Vol.35 (6), p.773-781

2017

Volltextzugriff (PDF)

Vascular complications in lumbar spinal surgery : Percutaneous endovascular treatment

Cardiovascular and interventional radiology, 2000-01, Vol.23 (1), p.65-69

2000

Volltextzugriff (PDF)

Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer

Oncology letters, 2017-08, Vol.14 (2), p.2385-2392

2017

Volltextzugriff (PDF)

A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy

Investigational new drugs, 2012-08, Vol.30 (4), p.1501-1510

2012

Volltextzugriff (PDF)

A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy

Investigational new drugs, 2012-04, Vol.30 (2), p.672-680

2012

Volltextzugriff (PDF)

A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer

Investigational new drugs, 2010-10, Vol.28 (5), p.650-658

2010

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

ThemaPatients

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(132)
Tagungsberichte
(1)

Sprache

Englisch
(133)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers

Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors

Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study - (NCT05103020) - study protocol

Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer

Machine Learning-Based Mortality Prediction Model for Critically Ill Cancer Patients Admitted to the Intensive Care Unit (CanICU)

Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer

Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer

Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma

Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery

Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent

A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study

Autonomy is not but competence and relatedness are associated with physical activity among colorectal cancer survivors

Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection

A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer

ARAF mutations confer resistance to the RAF inhibitobelvarafenib in melanoma

A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors

Vascular complications in lumbar spinal surgery : Percutaneous endovascular treatment

Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer

A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy

A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy

A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer

Aktive Filter

Suchergebnisse filtern